Extracorporeal Shockwave Lithotripsy Devices is the fastest growing segment, North America is the largest regional market
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Key Market Drivers
The escalating prevalence of urolithiasis and kidney stones is a significant driver for the global lithotripsy devices market, creating sustained demand for effective stone management solutions. Influenced by dietary habits, lifestyle shifts, and genetic factors, the patient population requiring intervention remains substantial. According to "Prevalence, Incidence, and Determinants of Kidney Stones in a Nationally Representative Sample of US Adults" in ResearchGate, published September 2025, the prevalence of kidney stones was 11.0% among US adults, underscoring a critical and expanding demographic.Key Market Challenges
The high capital cost associated with acquiring and maintaining advanced lithotripsy equipment significantly impedes the growth of the Global Lithotripsy Devices Market. This challenge is particularly pronounced in developing regions, where healthcare budgets are often constrained. The substantial initial investment required for these sophisticated machines, coupled with ongoing maintenance expenses, presents a considerable barrier for hospitals and healthcare providers, limiting their ability to upgrade existing technology or expand their service offerings.Key Market Trends
The growing preference for minimally invasive and outpatient procedures is significantly influencing the global lithotripsy devices market, driven by patient expectations for faster recovery and healthcare systems’ focus on improving cost efficiency. These procedures reduce patient discomfort, minimise infection risks, and enable quicker return to normal activities, supporting a shift away from conventional invasive surgical interventions. This evolution is reinforcing demand for advanced lithotripsy technologies that deliver effective outcomes with reduced clinical burden.This trend is further supported by the increasing emphasis on data-driven and efficient patient management. According to the American Urological Association’s 2024 Annual Report, the AUA Quality (AQUA) Registry expanded to include over 12 million patients from nearly 2,400 providers in 2023, highlighting the industry-wide push toward optimised care delivery and improved procedural efficiency. As a result, manufacturers are increasingly focused on developing lithotripsy devices tailored for outpatient environments, including portable, compact, and user-friendly systems that align with modern treatment settings.
Key Market Players Profiled:
- Zimmer MedizinSysteme GmbH
- Olympus Corporation
- Richard Wolf GmbH
- Boston Scientific Corporation
- STORZ Medical AG
- Takara Bio USA, Inc.
- TRINOVA BIOCHEM GmbH
- Upcyte Technologies GmbH
Report Scope:
In this report, the Global Lithotripsy Devices Market has been segmented into the following categories:By Type:
- Extracorporeal Shock Wave Lithotripsy Devices
- Intracorporeal Lithotripsy Devices
By Application:
- Kidney Stones
- Ureteral Stones
- Pancreatic Stones
- Bile Duct Stones
By End-User:
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Lithotripsy Devices Market.Available Customizations:
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
The companies profiled in this Lithotripsy Devices market report include:- Zimmer MedizinSysteme GmbH
- Olympus Corporation
- Richard Wolf GmbH
- Boston Scientific Corporation
- STORZ Medical AG
- Takara Bio USA, Inc.
- TRINOVA BIOCHEM GmbH
- Upcyte Technologies GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 185 |
| Published | November 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 2.81 Billion |
| Forecasted Market Value ( USD | $ 3.76 Billion |
| Compound Annual Growth Rate | 4.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |


